Screener
Janux Therapeutics JANX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
| Assets | June 30,2026 / (unaudited) | December 31,2025 |
|---|---|---|
| Total current assets | 983,337 | 975,887 |
| Restricted cash | 816 | 816 |
| Property and equipment, net | 3,260 | 3,852 |
| Operating lease right-of-use assets | 17,327 | 18,402 |
| Other long-term assets | 2,913 | 2,608 |
| Total assets | $1,007,653 | $1,001,565 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: |
Item 1. Financial Statements.
FAQ
- What is Janux Therapeutics's operating lease ROU assets?
- Janux Therapeutics (JANX) reported operating lease ROU assets of $17.33M in Q2 2026.
- How has Janux Therapeutics's operating lease ROU assets changed year-over-year?
- Janux Therapeutics's operating lease ROU assets decreased by 6.1% year-over-year, from $18.46M to $17.33M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Janux Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude